Gilman Hill Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
6,928
+125
| +2% | +$50.7K | 0.46% | 76 |
|
|
2025
Q1 | $3.39M | Buy |
6,803
+48
| +0.7% | +$23.9K | 0.59% | 67 |
|
|
2024
Q4 | $3.51M | Buy |
6,755
+273
| +4% | +$142K | 0.61% | 65 |
|
|
2024
Q3 | $4.01M | Buy |
6,482
+46
| +0.7% | +$28.5K | 0.67% | 58 |
|
|
2024
Q2 | $3.56M | Buy |
6,436
+79
| +1% | +$43.7K | 0.64% | 65 |
|
|
2024
Q1 | $3.69M | Buy |
6,357
+33
| +0.5% | +$19.2K | 0.66% | 59 |
|
|
2023
Q4 | $3.36M | Sell |
6,324
-23
| -0.4% | -$12.2K | 0.62% | 58 |
|
|
2023
Q3 | $3.21M | Buy |
6,347
+148
| +2% | +$74.9K | 0.63% | 57 |
|
|
2023
Q2 | $3.23M | Buy |
6,199
+169
| +3% | +$88.2K | 0.6% | 60 |
|
|
2023
Q1 | $3.48M | Buy |
6,030
+395
| +7% | +$228K | 0.71% | 53 |
|
|
2022
Q4 | $3.1M | Buy |
5,635
+958
| +20% | +$528K | 0.64% | 54 |
|
|
2022
Q3 | $2.37M | Sell |
4,677
-67
| -1% | -$34K | 0.55% | 58 |
|
|
2022
Q2 | $2.58M | Buy |
4,744
+559
| +13% | +$304K | 0.55% | 53 |
|
|
2022
Q1 | $2.47M | Buy |
4,185
+478
| +13% | +$282K | 0.56% | 60 |
|
|
2021
Q4 | $2.47M | Sell |
3,707
-75
| -2% | -$50K | 0.55% | 57 |
|
|
2021
Q3 | $2.16M | Buy |
3,782
+35
| +0.9% | +$20K | 0.55% | 62 |
|
|
2021
Q2 | $1.89M | Buy |
3,747
+826
| +28% | +$417K | 0.48% | 65 |
|
|
2021
Q1 | $1.33M | Buy |
2,921
+533
| +22% | +$243K | 0.37% | 76 |
|
|
2020
Q4 | $1.11M | Buy |
2,388
+148
| +7% | +$68.9K | 0.36% | 80 |
|
|
2020
Q3 | $989K | Sell |
2,240
-190
| -8% | -$83.9K | 0.38% | 72 |
|
|
2020
Q2 | $880K | Sell |
2,430
-8
| -0.3% | -$2.9K | 0.35% | 77 |
|
|
2020
Q1 | $691K | Buy |
+2,438
| New | +$691K | 0.34% | 85 |
|